Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, Vibrant Health Care, Inc., a biologics manufacturer, received an FDA Warning Letter on November 18, 2020, indicating significant regulatory compliance concerns. Without access to the full letter text or specified subject line, the specific violations cannot be detailed; however, the warning pertains to biologic products under FDA jurisdiction. The company should be presumed to have received citations for manufacturing, quality control, or other regulatory deficiencies requiring corrective action.